Score

1.43 /10
Danger

Viva Capital

Ukraine

2-5 years

Suspicious Regulatory License

Suspicious Scope of Business

High potential risk

Add brokers

Comparison

Expose

Exposure

Time Machine
Website

Score

Regulatory Index0.00

Business Index6.40

Risk Management Index0.00

Software Index4.00

License Index0.00

Time Machine
Website

Licenses

No valid regulatory information, please be aware of the risk

VPS Standard
No restriction on the broker account. Support service provided by WikiFX

Single Core

1G

40G

open now

Check whenever you want

Download App for complete information

Warning: Low score, please stay away!
Previous Detection : 2024-12-26
  • It has been verified that this broker currently has no valid regulation. Please be aware of the risk!

WikiFX Verification

Viva Capital · Company summary

General Information

Founded in June 2020, Viva Capital is a brokerage firm in Turkey that aims to provide its clients with a wide range of integrated financial services.

Regulatory Risk

It has been verified that Viva Capital currently has no valid regulatory, please be aware of the risk!

Market Instruments

Viva Capital offers investors a range of financial instruments, including Forex, stocks,

precious metals and cryptocurrencies.

Trading Platform

Viva Capital offers its clients access to the world's financial markets via the MetaTrader 5 (MT5) platform. The platform is available in different versions that are suited to use in any device, PC, Mobile or through the Application.

Supported Language

Viva Capital only supports Arabic language access in a single format, which may not be very friendly to traders from other countries.

Contact Information

Users can contact Viva Capital for inquiries through a variety of channels, including Youtube, Facebook, Instagram and Twitter. Also, the broker can be reached through the email: info@vivacapitalmarkets.com. Office Address: Ukraine, 82106, Lviv region, Drohobych, Hrushevskoho Mikhaila St, house 89, building 2, Apt 16.

User Reviews

More

User comment

0

Comments

Write a review

No comment yet

start to write first comment